STAAR Surgical Profit Margin 2010-2023 | STAA

Current and historical gross margin, operating margin and net profit margin for STAAR Surgical (STAA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. STAAR Surgical net profit margin as of December 31, 2023 is 6.62%.
STAAR Surgical Annual Profit Margins
STAAR Surgical Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.433B $0.322B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $68.728B 18.40
Becton Dickinson (BDX) United States $67.941B 19.73
West Pharmaceutical Services (WST) United States $27.818B 47.03
Cardinal Health (CAH) United States $25.564B 15.37
Align Technology (ALGN) United States $23.702B 47.80
Cooper (COO) United States $18.588B 28.13
Labcorp (LH) United States $17.307B 14.78
Henry Schein (HSIC) United States $9.123B 15.78
DENTSPLY SIRONA (XRAY) United States $6.490B 17.10
Merit Medical Systems (MMSI) United States $4.217B 24.13
CONMED (CNMD) United States $2.296B 21.62
Patterson (PDCO) United States $2.281B 10.93
Atrion (ATRI) United States $0.703B 36.21
Lifevantage (LFVN) United States $0.080B 12.90
Pro-Dex (PDEX) United States $0.063B 24.05
Biolase (BIOL) United States $0.005B 0.00